119 related articles for article (PubMed ID: 2150599)
21. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
[TBL] [Abstract][Full Text] [Related]
22. Fos and Jun form cell specific protein complexes at the neuropeptide tyrosine promoter.
Jalava A; Mai S
Oncogene; 1994 Aug; 9(8):2369-75. PubMed ID: 8036020
[TBL] [Abstract][Full Text] [Related]
23. V-erbA and c-erbA proteins enhance transcriptional activation by c-jun.
Sharif M; Privalsky ML
Oncogene; 1992 May; 7(5):953-60. PubMed ID: 1349165
[TBL] [Abstract][Full Text] [Related]
24. Altered transcriptional activity of c-fos promoter plasmids in v-raf-transformed NIH 3T3 cells.
Siegfried Z; Ziff EB
Mol Cell Biol; 1990 Nov; 10(11):6073-8. PubMed ID: 2122238
[TBL] [Abstract][Full Text] [Related]
25. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters.
Schönthal A; Herrlich P; Rahmsdorf HJ; Ponta H
Cell; 1988 Jul; 54(3):325-34. PubMed ID: 2840203
[TBL] [Abstract][Full Text] [Related]
26. [The serum element (SRE)--the probable target for the negative control in the regulation of the proto-oncogene c-fos promoter].
Pospelova TV; Volkov IV; Kukushkin AN; Svetlikova SB; Pospelov VA
Dokl Akad Nauk SSSR; 1990; 315(4):1003-6. PubMed ID: 2097133
[No Abstract] [Full Text] [Related]
27. Analysis of temperature-sensitive functions of Fos: lack of a correlation between transformation and TRE-dependent trans-activation.
Jooss K; Müller R
Oncogene; 1992 Oct; 7(10):1933-9. PubMed ID: 1408134
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional activation by TGF beta 1 mediated by the dyad symmetry element (DSE) and the TPA responsive element (TRE).
de Groot RP; Kruijer W
Biochem Biophys Res Commun; 1990 May; 168(3):1074-81. PubMed ID: 2111989
[TBL] [Abstract][Full Text] [Related]
29. fos/jun repression of cardiac-specific transcription in quiescent and growth-stimulated myocytes is targeted at a tissue-specific cis element.
McBride K; Robitaille L; Tremblay S; Argentin S; Nemer M
Mol Cell Biol; 1993 Jan; 13(1):600-12. PubMed ID: 8417355
[TBL] [Abstract][Full Text] [Related]
30. A common cellular pathway for v-mos and v-Ki-ras is not required for v-Ki-ras-induced tumorigenicity in a nonmalignant, v-mos-expressing revertant cell.
Gerfaux J; Sergiescu D; Hamelin R; Joret AM; Lallemand C
Mol Carcinog; 1990; 3(2):103-13. PubMed ID: 2161237
[TBL] [Abstract][Full Text] [Related]
31. Suppression of dexamethasone-induced metallothionein expression and cis-diamminedichloroplatinum(II) resistance by v-mos.
Basu A; Lazo JS
Cancer Res; 1991 Feb; 51(3):893-6. PubMed ID: 1824827
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of genistein on a tumor promoter-induced c-fos and c-jun expression in mouse skin.
Wei H; Barnes S; Wang Y
Oncol Rep; 1996 Jan; 3(1):125-8. PubMed ID: 21594328
[TBL] [Abstract][Full Text] [Related]
33. trans-repression of the mouse c-fos promoter: a novel mechanism of Fos-mediated trans-regulation.
Lucibello FC; Lowag C; Neuberg M; Müller R
Cell; 1989 Dec; 59(6):999-1007. PubMed ID: 2513130
[TBL] [Abstract][Full Text] [Related]
34. An inhibitory Raf-1 mutant suppresses expression of a subset of v-raf-activated genes.
Miltenberger RJ; Cortner J; Farnham PJ
J Biol Chem; 1993 Jul; 268(21):15674-80. PubMed ID: 8340392
[TBL] [Abstract][Full Text] [Related]
35. Multiple sequence elements in the c-fos promoter mediate induction by cAMP.
Fisch TM; Prywes R; Simon MC; Roeder RG
Genes Dev; 1989 Feb; 3(2):198-211. PubMed ID: 2541049
[TBL] [Abstract][Full Text] [Related]
36. The dyad symmetry element is the molecular target for c-fos induction and inhibition during K 562 differentiation along mutually exclusive lineages.
Trouche D; Robin P; Sassone-Corsi P; Farrar WL; Harel-Bellan A
Blood; 1991 Jan; 77(1):55-63. PubMed ID: 1898633
[TBL] [Abstract][Full Text] [Related]
37. The inner core of the serum response element mediates both the rapid induction and subsequent repression of c-fos transcription following serum stimulation.
Rivera VM; Sheng M; Greenberg ME
Genes Dev; 1990 Feb; 4(2):255-68. PubMed ID: 2110922
[TBL] [Abstract][Full Text] [Related]
38. Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences.
Sheng M; Dougan ST; McFadden G; Greenberg ME
Mol Cell Biol; 1988 Jul; 8(7):2787-96. PubMed ID: 3136322
[TBL] [Abstract][Full Text] [Related]
39. Identification of a negative regulatory element that inhibits c-mos transcription in somatic cells.
Zinkel SS; Pal SK; Szeberényi J; Cooper GM
Mol Cell Biol; 1992 May; 12(5):2029-36. PubMed ID: 1533271
[TBL] [Abstract][Full Text] [Related]
40. Production and characterization of a monoclonal antibody to the v-mos oncogene protein.
Ishikawa K; Kurata N; Aoki H; Kato T; Marunouchi T
Hybridoma; 1991 Jun; 10(3):357-68. PubMed ID: 1833309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
